• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday

    8/31/22 5:50:17 AM ET
    $AA
    $ABVC
    $AHI
    $AMST
    Aluminum
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AA alert in real time by email

    Gainers

    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
    • NewAge, Inc. (NASDAQ:NBEV) shares jumped 74.2% to close at $0.3632 on Tuesday.
    • IN8bio, Inc. (NASDAQ:INAB) surged 39.4% to settle at $2.76 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02. HC Wainwright & Co. initiated coverage on IN8bio with a Buy rating and announced a price target of $14.
    • TMC the metals company Inc. (NASDAQ:TMC) jumped 33.3% to close at $1.12. The company recently posted a quarterly loss of $0.05 per share.
    • TDH Holdings, Inc. (NASDAQ:PETZ) rose 29.3% to settle at $4.81. The company recently announced it acquired all of the equity interest of Beijing Wenxin Company from Kargo Services.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) gained 25.9% to close at $1.02.
    • OKYO Pharma Limited (NASDAQ:OKYO) gained 21.2% to close at $2.4361. OKYO Pharma plans Q4 IND filing of OK-101 to treat dry eye disease with subsequent Phase 2 initiation.
    • Forge Global Holdings, Inc. (NYSE:FRGE) rose 20.9% to close at $4.17.
    • Liquid Media Group Ltd. (NASDAQ:YVR) jumped 17.7% to settle at $0.4723 after the company reported Q2 sales results up year over year.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares gained 17.2% to close at $3.34 after a 13D Filing showed Cincinnati Cornerstone Investors reported a 22.9% stake in the company.
    • American Outdoor Brands, Inc. (NASDAQ:AOUT) jumped 17.1% to close at $9.10 after B. Riley upgraded the stock from Neutral to Buy and announced an $11 price target.
    • ECMOHO Limited (NASDAQ:MOHO) rose 16.7% to settle at $0.1715.
    • DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) jumped 16.7% to close at $10.76.
    • International Game Technology announced an agreement to settle legal proceedings related to Benson V. Double Down Interactive.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) gained 16% to close at $0.9524. ABVC BioPharma recently said Phase II Vitargus clinical trial received Local Ethics Committee approval in Thailand.
    • Hour Loop, Inc. (NASDAQ:HOUR) surged 15.2% to settle at $3.78.
    • Tuesday Morning Corporation (NASDAQ:TUEM) rose 14.5% to close at $0.3666.
    • Mega Matrix Corp. (NYSE:MTMT) gained 14.3% to close at $1.52.
    • Avid Technology, Inc. (NASDAQ:AVID) gained 12.1% to close at $27.04. Avid Technology will replace Plantronics in the S&P SmallCap 600 on Thursday, September 1.
    • Augmedix, Inc. (NASDAQ:AUGX) rose 12.1% to settle at $1.85. Augmedix recently posted Q2 sales of $7.33 million.
    • Big Lots, Inc. (NYSE:BIG) surged 11.7% to close at $24.08 after the company reported a second-quarter FY22 sales decline of 7.6% year-on-year to $1.346 billion, marginally beating the consensus of $1.34 billion. Comparable sales decreased 9.2%.
    • 8x8, Inc. (NYSE:EGHT) fell 11.2% to close at $5.27.
    • American Woodmark Corporation (NASDAQ:AMWD) rose 10.5% to close at $52.44 after reporting better-than-expected Q1 results.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) rose 7.9% to close at $3.54.
    • FaZe Holdings Inc. (NASDAQ:FAZE) rose 7.3% to close at $18.22.
    • Check-Cap Ltd. (NASDAQ:CHEK) gained 6.7% to close at $0.44 after gaining over 4% on Monday.
    • Getty Images Holdings, Inc. (NYSE:GETY) rose 6.4% to settle at $21.43.
    • Xometry, Inc. (NASDAQ:XMTR) gained 5.4% to settle at $51.08.

     

    Losers

    • Amesite Inc. (NASDAQ:AMST) shares tumbled 51.5% to close at $0.4038 on Tuesday after the company announced a $2.3 million registered direct offering.
    • Baudax Bio, Inc. (NASDAQ:BXRX) shares dipped 43.1% to settle at $0.3105 after the company reported pricing of $6.2 million public offering.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 36.9% to close at $0.0990. Clarus Therapeutics shares dipped 23% on Monday after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.
    • Liquidia Corporation (NASDAQ:LQDA) fell 30.4% to close at $5.38.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 26.5% to close at $0.97. Advanced Human Imaging shares jumped 94% on Monday after the company announced it signed a Master Services Agreement with Activate Health OÜ.
    • Azure Power Global Limited (NYSE:AZRE) dropped 26.3% to close at $4.31 after Credit Suisse downgraded the stock from Outperform to Underperform and lowered its price target from $22 to $5.
    • The OLB Group, Inc. (NASDAQ:OLB) fell 25% to close at $1.50.
    • Sentage Holdings Inc. (NASDAQ:SNTG) shares fell 24.6% to close at $3.77 on possible profit taking after the stock surged Monday.
    • FiscalNote Holdings, Inc. (NYSE:NOTE) declined 24.4% to settle at $7.46. BTIG initiated coverage on FiscalNote Holdings with a Buy rating and announced a price target of $14.
    • AMTD Digital Inc. (NYSE:HKD) fell 24.2% to close at $105.00. Shares of technology companies traded lower amid overall market weakness as stocks continue to fall following last week's comments from Fed Chair Powell, which indicated the Fed will remain aggressive in its monetary policy stance to fight inflation.
    • Photronics, Inc. (NASDAQ:PLAB) fell 23.6% to close at $16.64. Photronics posted upbeat Q3 results, but issued weak outlook for the current quarter.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) fell 23.1% to close at $2.27.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) fell 22.7% to close at $6.47 on profit-taking after the stock surged following its IPO.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) declined 21.3% to close at $5.07 as the stock sees volatility following its IPO last Tuesday.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) dropped 21.1% to close at $0.99. Morgan Stanley downgraded Cabaletta Bio from Overweight to Equal-Weight and lowered the price target from $15 to $3.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) fell 20.5% to close at $1.75. The company recently priced its IPO at $5 per unit.
    • Cross Timbers Royalty Trust (NYSE:CRT) fell 20% to close at $19.70. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Kuke Music Holding Limited (NYSE:KUKE) dropped 18.8% to settle at $0.84.
    • Yiren Digital Ltd. (NYSE:YRD) declined 18.2% to close at $0.7051.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) fell 17.7% to close at $5.43.
    • Winc, Inc. (NYSE:WBEV) dropped 17.4% to close at $1.00. Winc recently posted a Q2 loss of $0.32 per share.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) fell 16.9% to close at $7.60.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 16.5% to close at $0.8350.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) fell 15.9% to close at $3.61 after the company reported top line data from Phase 2 SELECT trial evaluating Vopratelimab.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 15% to close at $1.19.
    • Houston American Energy Corp. (NYSE:HUSA) fell 14.7% to close at $4.23.
    • REX American Resources Corporation (NYSE:REX) fell 14.5% to close at $28.75. The company reported upbeat quarterly earnings.
    • UTStarcom Holdings Corp. (NASDAQ:UTSI) dropped 14.4% to settle at $3.38.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) declined 13.6% to close at $0.20. Ladenburg Thalmann recently initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
    • Silver Crest Acquisition Corporation (NASDAQ:SLCR) fell 13.5% to close at $8.78.
    •  
    • BrainsWay Ltd. (NASDAQ:BWAY) fell 13.3% to close at $4.03. The FDA, on Monday, granted 510(k) clearance to BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) H7 Coil for its use in treating adults suffering from major depressive disorder and depression, including those with comorbid anxiety symptoms commonly known as anxious depression.
    • Veru Inc. (NASDAQ:VERU) fell 9.8% to close at $14.88.
    • iQIYI, Inc. (NASDAQ:IQ) declined 9.7% to close at $3.55 after the company reported Q2 earnings results.
    • Nikola Corporation (NASDAQ:NKLA) fell 9.4% to close at $5.41 after the company filed a prospectus related to the issuance and sale of common stock from time to time up to $400 million. The company also announced an exchange offer to purchase all outstanding shares of Romeo Power.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) fell 9.2% to close at $5.52.
    • Alcoa Corporation (NYSE:AA) dropped 8.5% to close at $50.79. Alcoa to curtail one third of production capacity at Lista Smelter in Norway to mitigate high energy costs.
    • Arch Resources, Inc. (NYSE:ARCH) fell 6.8% to settle at $147.27.
    • Helmerich & Payne, Inc. (NYSE:HP) dropped 6.5% to close at $42.48. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Baidu, Inc. (NASDAQ:BIDU) declined 6.5% to close at $137.69 after the company reported Q2 EPS results.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ABVC
    $AHI
    $AMST

    CompanyDatePrice TargetRatingAnalyst
    Bright Minds Biosciences Inc.
    $DRUG
    4/13/2026$145.00Buy
    Jefferies
    Alcoa Corporation
    $AA
    4/9/2026$80.00Equal-Weight → Overweight
    Morgan Stanley
    Baidu Inc. ADS
    $BIDU
    4/1/2026$161.00Outperform
    BNP Paribas Exane
    Photronics Inc.
    $PLAB
    3/20/2026$46.00Buy
    Lake Street
    Helmerich & Payne Inc.
    $HP
    3/20/2026$43.00In-line → Outperform
    Evercore ISI
    Alcoa Corporation
    $AA
    3/13/2026$68.00Underweight → Neutral
    Analyst
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    Melco Resorts & Entertainment Limited
    $MLCO
    2/17/2026$9.50Neutral → Buy
    UBS
    More analyst ratings

    $AA
    $ABVC
    $AHI
    $AMST
    SEC Filings

    View All

    SEC Form 6-K filed by Melco Resorts & Entertainment Limited

    6-K - Melco Resorts & Entertainment LTD (0001381640) (Filer)

    4/24/26 6:30:11 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    Mobile Global Esports Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Mobile Global Esports, Inc. (0001886362) (Filer)

    4/23/26 9:23:24 PM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form RW filed by Amesite Inc.

    RW - Amesite Inc. (0001807166) (Filer)

    4/23/26 1:00:37 PM ET
    $AMST
    Computer Software: Prepackaged Software
    Technology

    $AA
    $ABVC
    $AHI
    $AMST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weymouth Katharine bought $49,997 worth of shares (1,215 units at $41.15) (SEC Form 4)

    4 - Xometry, Inc. (0001657573) (Issuer)

    3/2/26 6:15:05 PM ET
    $XMTR
    Real Estate

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President, Science & Tech. Binder Gwendolyn bought $24,763 worth of shares (11,312 units at $2.19), increasing direct ownership by 57% to 31,312 units (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:30 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Bright Minds Biosciences with a new price target

    Jefferies initiated coverage of Bright Minds Biosciences with a rating of Buy and set a new price target of $145.00

    4/13/26 8:51:07 AM ET
    $DRUG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Alcoa upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Alcoa from Equal-Weight to Overweight and set a new price target of $80.00

    4/9/26 8:21:40 AM ET
    $AA
    Aluminum
    Industrials

    BNP Paribas Exane initiated coverage on Baidu with a new price target

    BNP Paribas Exane initiated coverage of Baidu with a rating of Outperform and set a new price target of $161.00

    4/1/26 8:26:04 AM ET
    $BIDU
    Computer Software: Programming Data Processing
    Technology

    $AA
    $ABVC
    $AHI
    $AMST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iQIYI Returns to LVL UP EXPO 2026 in Las Vegas with Blacklyte, Debuting Peter Pau AI Theater and Immersive AI Experiences

    LAS VEGAS, April 24, 2026 /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte. Founded in 2010, iQIYI (NASDAQ:IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.Experience the Future of AI StorytellingAt this year's LVL UP EXPO, iQIYI debu

    4/24/26 8:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Xometry to Announce First Quarter 2026 Financial Results on May 7, 2026

    NORTH BETHESDA, Md., April 23, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced it will report its first quarter 2026 financial results before the market opens on May 7, 2026. Xometry will host its conference call and webcast to discuss the results at 8:30 a.m. ET (5:30 a.m. PT) on the same day. In addition to its press release announcing its first quarter 2026 financial results, Xometry will also release an earnings presentation, which will be available on its Investor Relations website. Xometry, Inc. Q1 2026 Earnings Presentation and Conference Call Thursday, May 7, 20268:30

    4/23/26 9:05:00 AM ET
    $XMTR
    Real Estate

    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, April 28, 2026 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in Australia, China, Hong Kong, Portugal, Netherlands, Cayman Islands and France, will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live presentations and/or ask qu

    4/23/26 8:35:00 AM ET
    $BLTE
    $HCM
    $LOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    $AA
    $ABVC
    $AHI
    $AMST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Huang Jingsheng claimed ownership of 52,076 units of Ordinary Shares (SEC Form 3)

    3 - Yiren Digital Ltd. (0001631761) (Issuer)

    4/23/26 4:25:26 PM ET
    $YRD
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Daniels Eric Joseph

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    4/22/26 5:00:04 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Resnik Josh

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    4/21/26 9:16:06 PM ET
    $NOTE
    Real Estate

    $AA
    $ABVC
    $AHI
    $AMST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    Leadership Updates

    Live Leadership Updates

    View All

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

    HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announced the appointment of Eric J. Daniels, M.D., MBA, as Chief Development Officer, effective April 20, 2026. Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most recently served as Chief Development Officer at Kiora Pharmaceuticals , where he oversaw the company's full development portfolio

    4/9/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    Financials

    Live finance-specific insights

    View All

    Xometry to Announce First Quarter 2026 Financial Results on May 7, 2026

    NORTH BETHESDA, Md., April 23, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced it will report its first quarter 2026 financial results before the market opens on May 7, 2026. Xometry will host its conference call and webcast to discuss the results at 8:30 a.m. ET (5:30 a.m. PT) on the same day. In addition to its press release announcing its first quarter 2026 financial results, Xometry will also release an earnings presentation, which will be available on its Investor Relations website. Xometry, Inc. Q1 2026 Earnings Presentation and Conference Call Thursday, May 7, 20268:30

    4/23/26 9:05:00 AM ET
    $XMTR
    Real Estate

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

    BEIJING, April 23, 2026 /PRNewswire/ -- Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu's management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time). Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of "Baidu Inc. Q1 2026 Earnings Conference Call". Please follow t

    4/23/26 5:00:00 AM ET
    $BIDU
    Computer Software: Programming Data Processing
    Technology

    $AA
    $ABVC
    $AHI
    $AMST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 3:36:55 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care